1. Mendes FF, Carvalho LIM, Lopes MB. Glucagon-Like Peptide-1 agonists in perioperative medicine: to suspend or not to suspend, that is the question. Braz J Anesthesiol. 2024;74:844538.

2. Mizubuti GB, Ho AMH, Silva LMD, Phelan R. Perioperative management of patients on glucagon-like peptide-1 receptor agonists. Curr Opin Anaesthesiol. 2024;37:323−33.

3. Oprea AD, Umpierrez GE, Sweitzer B, Hepner DL. Perioperative Management of Patients Taking Glucagon-like Peptide-1 Receptor Agonists: Applying Evidence to Clinical Practice. Anesthesiology. 2024;141:1141−61.

4. Do Nascimento TS, Pereira ROL, Maia E, et al. The impact of glucagon-like peptide-1 receptor agonists in the patients undergoing anesthesia or sedation: systematic review and meta-analysis. Perioper Med. 2024;13:78.

5. Kindel TL, Wang AY, Wadhwa A, et al. Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period. Surg Obes Relat Dis. 2024;20:1183−6.

6. Marino EC, Negretto L, Ribeiro RS, Momesso D, Feitosa ACR, Bertoluci M. Rastreio e Controle da Hiperglicemia no Perioperatorio.
Em: Diretriz da Sociedade Brasileira de Diabetes [Internet]. 2023.a ed. Conectando Pessoas; 2023 [cited 2025 May 05]. Available from: https://diretriz.diabetes.org.br/rastreio-e-controleda-hiperglicemia-no-perioperatorio/.

7. El-Boghdadly K, Dhesi J, Fabb P, et al. Elective peri-operative management of adults taking glucagon-like peptide-1 receptor agonists, glucose-dependent insulinotropic peptide agonists and sodium-glucose cotransporter-2 inhibitors: a multidisciplinary consensus statement: A consensus statement from the Association of Anaesthetists, Association of British Clinical Diabetologists, British Obesity and Metabolic Surgery Society, Centre for Perioperative Care, Joint British Diabetes Societies for Inpatient Care, Royal College of Anaesthetists, Society for Obesity and Bariatric Anaesthesia and UK Clinical Pharmacy Association. Anaesthesia. 2025;80:412−24.

8. Maselli DB, Lee D, Bi D, et al. Safe Continuation of Glucagon-like Peptide 1 Receptor Agonists at Endoscopy: A Case Series of 57 Adults Undergoing Endoscopic Sleeve Gastroplasty. Obes Surg. 2024;34(7):2369−74.

9. Clinical Practice Recommendation on Periprocedural Use Of GLP1/GIP Receptor Agonists - Australian Diabetes Society (ADS), National Association of Clinical Obesity Services (NACOS), Gastroenterological Society of Australia (GSA) and Australian and New Zealand College of Anaesthetists (ANZCA). [cited 2025 May 05]. Available from: https://www.diabetessociety.com.au/ resource-periprocedural-use-glp1-gip-ras-june-2024/; 2024.